Z83. 2 - Family history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | ICD-10-CM.
Heterozygous means that the 2 copies of a gene are different. In your case, one of your Factor V gene codes is for normal clotting Factor V and the other Factor V gene code is for Factor V Leiden. There is more risk of a blood clot if both gene codes are for Factor V Leiden (ie in the homozygous state).
ICD-10 code D68. 9 for Coagulation defect, unspecified is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .
Factor V Leiden (FVL), or factor “5” Leiden, is a genetic mutation (change) that makes the blood more prone to abnormal clotting. Factor V Leiden is the most common genetic predisposition to blood clots.
Factor V Leiden is a common change in a gene that controls a protein called Factor V. Factor V is a protein involved in blood clotting and the Factor V Leiden gene change (also called mutation) is linked to an increase risk of blood clots.
Having 1 Factor V Leiden gene (heterozygous type) slightly increases the chance of developing a blood clot. Having 2 Factor V Leiden genes (homozygous type) makes the risk much greater. Having Factor V Leiden does not appear to increase the chances of developing a heart attack or stroke.
NCD - Partial ThromboplastinTime (PTT) (190.16)
01 Long term (current) use of anticoagulants.
To assign D68. 9, the provider needs to specifically diagnose and documented by the provider, as well as indicate it is not contributed to a prescribed anticoagulant therapy.
Factor V Leiden thrombophilia is an inherited disorder of blood clotting .
The Factor V variant known as Factor V Leiden (or rs6025) is associated with an approximately 300% increased risk in heterozygotes and an up to 8000% increased risk in homozygotes. The Factor II rs1799963 polymorphism (or G20210A) may also independently increase the risk by approximately 200%.
Group 1CodeDescription81241F5 (COAGULATION FACTOR V) (EG, HEREDITARY HYPERCOAGULABILITY) GENE ANALYSIS, LEIDEN VARIANT81291MTHFR (5,10-METHYLENETETRAHYDROFOLATE REDUCTASE) (EG, HEREDITARY HYPERCOAGULABILITY) GENE ANALYSIS, COMMON VARIANTS (EG, 677T, 1298C)1 more row
A blood coagulation disorder characterized by the complete absence of fibrinogen in the blood, resulting in bleeding. A deficiency of blood coagulation factor v (known as proaccelerin or accelerator globulin or labile factor) leading to a rare hemorrhagic tendency known as owren's disease or parahemophilia.
A usually inherited blood coagulation disorder characterized by the partial or complete absence of fibrinogen in the blood, resulting in bleeding. A very rare autosomal recessive inherited blood coagulation disorder characterized by deficiency of factor v, resulting in bleeding.